Shaun Passley - 18 Mar 2026 Form 3 Insider Report for ZenaTech, Inc. (ZENA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 09:47:06 UTC
Prior SEC filing
21 Apr 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Shaun Passley

Key filing fact

Shaun Passley filed Form 3 for ZenaTech, Inc. (ZENA) on 18 Mar 2026.

Key facts

  • This page summarizes Shaun Passley's Form 3 filing for ZenaTech, Inc. (ZENA).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 09:47.

Change

  • Previous filing in this sequence was filed on 21 Apr 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001671957 Primary reporting owner

Passley Shaun

Relationship
Chief Executive Officer, Director, 10%+ Owner
Address
201 W. LAKE ST. 135, CH
Signature
Shaun Passley
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZENA holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,668,205
Date
18 Mar 2026
Ownership
Direct
ZENA holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,867,301
Date
18 Mar 2026
Ownership
Owned by Epazz Inc., a company controlled by Dr. Passley
ZENA holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,583,333
Date
18 Mar 2026
Ownership
Owned by Ameritek Ventures, Inc., a company controlled by Dr. Passley.
ZENA holding

Super Voting Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
35,000
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1
ZENA holding

Super Voting Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
145,000
Date
18 Mar 2026
Ownership
Owned by Epazz Inc., a company controlled by Dr. Passley
Footnotes
F1
ZENA holding

Super Voting Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,000
Date
18 Mar 2026
Ownership
Owned by Ameritek Ventures, Inc., a company controlled by Dr. Passley.
Footnotes
F1
ZENA holding

Preferred Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,120,000
Date
18 Mar 2026
Ownership
Direct
Footnotes
F2
ZENA holding

Preferred Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,700,000
Date
18 Mar 2026
Ownership
Owned by Epazz Inc., a company controlled by Dr. Passley
Footnotes
F2
ZENA holding

Preferred Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
750,000
Date
18 Mar 2026
Ownership
Owned by Ameritek Ventures, Inc., a company controlled by Dr. Passley.
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The holders of Super Voting Shares are entitled to 1,000 votes per share on all matters submitted to a vote of the shareholders, whether at a meeting or by written consent, and vote together with the holders of the common shares as a single class, except as otherwise required by law or the Company's constating documents.

Footnote F2

Each issued Preferred Share is convertible, at the option of the holder, into three Common Shares with five business days' notice, provided that no conversion will take place until all holders of the issued Preferred Shares consent to such a conversion.

SEC remarks

Each preference share converts to 3 common shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .